GlassScriptPhysician profile
Laura Beacham
NPI 1124489380
$3,651.34
in general payments reported to CMS, 2019-2025
21 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $837 · 2023: $1,097 · 2024: $566 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,693.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $842.44 | 2022-2025 | |
| Incyte Corporation | $507.83 | 2022-2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $390.30 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $310.84 | 2022-2024 | Winlevi, Absorica Ld, Blu-U |
| Pfizer INC. | $234.44 | 2021-2024 | |
| Arcutis Biotherapeutics, INC. | $213.72 | 2023-2025 | Zoryve |
| Organon LLC | $198.69 | 2025 | Vtama |
| Lilly USA, LLC | $178.56 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Galderma Laboratories, L.P. | $172.88 | 2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $149.97 | 2022-2023 | Dupixent |
| Leo Pharma INC. | $136.45 | 2022-2025 | Adbry, Anzupgo |
| Mayne Pharma Commercial LLC | $75.13 | 2022-2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.47 | 2024-2025 | Jublia, Siliq, Cabtreo |
| Genzyme Corporation | $41.49 | 2023-2024 | |
| Dermavant Sciences, INC. | $40.46 | 2023-2024 | Vtama |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $27.54 | 2024 | Otezla |
| Verrica Pharmaceuticals INC. | $27.04 | 2024 | Ycanth |
| Botanix Sb INC | $20.59 | 2025 | Sofdra |
| Sanofi-Aventis U.S. LLC | $14.38 | 2021 | |
| Phadia US INC. | $13.19 | 2023 | Immunocap |
| Strata Skin Sciences, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Beacham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.